Amany Mohamed Ali Ahmed

معهد جنوب مصر للأورام

جامعة اسيوط

القسم
قسم أورام الأطفال
رقم الفاكس
N/A
البريد الالكتروني:
amanyamro194@yahoo.com
البريد الالكتروني MIS
dr_amanymohamed@aun.edu.eg
رقم الموبايل
01065658323/010
رقم المكتب
N/A - 04252
رابط الباحث العلمي لجوجل
google_scholar


دكتوراه ﻒﻳ طب أورام أطفال () , , 2007

أستاذ معهد جنوب مصر للأورام , جامعة أسيوط , 2017
أستاذ مساعد معهد جنوب مصر للأورام , جامعة أسيوط , 2013
مدرس معهد جنوب مصر للأورام , جامعة اسيوط , 2007
مدرس مساعد معهد جنوب مصر للأورام , جامعة اسيوط , 2001


رئيس قسم - معهد جنوب مصر للأورام, جامعة أسيوط , منذ 2013-08-01

# عنوان البحث Research Year
1 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response 2022
2 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute 2022
3 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt 2022
4 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
5 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt 2021
6 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt 2021
7 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		2021
8 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
9 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		2021
10 Neutropenic enterocolitis in pediatric leukemia patients treated with intensive chemotherapy in Upper Egypt 2020
11 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom 2018
12 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		2018
13 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
 		2018
14 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
15 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
16 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
17 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
18 P-459 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
19 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy 2017
20 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or
relapsed pediatric solid tumours
 		2016
21 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
22 Pattern of Pediatric Tumors at Pediatric Department in South Egypt Cancer Institute 2016
23 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
24 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
25 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
26 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
27 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
28 Pierre Marquet, Nicolas Picard Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients 2015
29 Clinicolaboratory Characteristics and Treatment Outcome of Pediatric Acute Lymphoblastic Leukemia at South Egypt Cancer Institute 2015
30 Castleman's Disease as a Rare Differential Diagnosis of Lymphadenopathy: 2 Case Reports and Review of Literature 2015
31 Outcome of Adolescents with Acute Lymphoblastic LeukemiaTreated by Pediatrics versus Adults Protocols 2014
32 • Risk-adapted Therapy of Pediatric Hodgkin Lymphoma in Upper Egypt 2014
33 Sacrococcygeal tumors: clinical characteristics and outcome of pediatric patients treated at South Egypt Cancer Institute. A retrospective analysis. 2013
34 Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. 2013
35 Risk Stratification Treatment of Pediatric Rhabdomyosarcoma: South Egypt Cancer Institute experience 2012
36 Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience 2011
37 Long-term Follow-up of Infantile Wilms Tumor Treated According to International Society of Pediatric Oncology Protocol: Seven Years' Follow-up 2010
38 Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: A retrospective study 2010

1 - محمود معتز محمد إبراهيم , دراسة للاضطرابات المعرفية للأطفال المصابين بمرض سرطان الدم الليمفاوي الحاد الذين يتلقون علاج وقائي للمخ ,2012-06-30
المشرفون: محمد حمدى غزالى، أمانى محمد على، هبة عبدالرازق سيد

2 - هبة حسن حسين حسن , أنماط الأورام الصلبة لدى الأطفال بقسم الأطفال بمركز أورام سوهاج ,2012-06-30
المشرفون: محمد محمود حمدى غزالى، أمانى محمد على، هبة عبدالرازق سيد

3 - صلاح فرغلى عثمان أحمد , تقييم الطفل المشتبه اصابته بالسرطان ,2012-06-30
المشرفون: محمد حمدى غزالى، أمانى محمد على، هبة عبدالرازق سيد
 

الجمعيات العلمية و النقابات :